Welcome to search season, Old Nassau. Princeton is in the market for a new women’s basketball coach after Northwestern hired Carla Berube on Wednesday night to take over its struggling program. Berube ...

Carla Berube is about to take on a massive rebuilding project in the Big Ten. Northwestern announced Wednesday afternoon that it had hired Berube as its next head coach for women’s basketball. She has ...

“Top Chef” star Carla Hall is opening a brand-new Southern fried chicken joint in Washington, D.C., celebrating the “culinary matriarch” in her family. On Saturday, March 14, the 61-year-old runway ...

It's finally here! After what has felt like an actual eternity, Harry Styles' fourth studio album Kiss All The Time. Disco, Occasionally has finally arrived, and it's safe to say we won't be listening ...

Meghana Keshavan covers biotech and contributes to The Readout newsletter. Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

About four years after the case was filed—and against the backdrop of a significantly changed COVID-19 vaccine landscape—Moderna has resolved a long-running patent feud. Moderna will pay $950 million ...

Feb 19 (Reuters) - German biopharmaceutical company BioNTech (22UAy.DE), opens new tab sued Moderna (MRNA.O), opens new tab in Delaware federal court on Thursday, alleging that Moderna's COVID-19 shot ...

The Food and Drug Administration’s decision, made public on Feb. 10, 2026, to not review an application to approve Moderna’s proposed mRNA-based flu vaccine set off a firestorm of criticism from ...

Megan Cerullo is a New York-based reporter for CBS MoneyWatch covering small business, workplace, health care, consumer spending and personal finance topics. She regularly appears on CBS News 24/7 to ...

The Food and Drug Administration (FDA) has backtracked its initial decision last week of refusing to review Moderna’s mRNA flu vaccine candidate after holding a high-priority meeting with the company.

A federal judge in Delaware has thrown out two key defenses Moderna (MRNA) had been claiming in its ongoing patent litigation with Arbutus Biopharma (ABUS) regarding its mRNA COVID-19 vaccine. Judge ...